Pfizer Wins Belgian Court Order: Poland and Romania Must Accept $2.2 Billion in COVID Vaccine Doses

A Belgian court has ordered the governments of Poland and Romania to accept and pay for over $2.2 billion worth of COVID-19 vaccine doses from Pfizer. This ruling represents a significant legal and financial escalation in the long-running dispute between the pharmaceutical giant and the two EU member states, which had sought to renegotiate or cancel their massive supply contracts signed during the pandemic's peak.

The case, adjudicated in a Brussels court, centers on the binding nature of the advance purchase agreements signed by the European Commission on behalf of member states. Poland and Romania had argued that the contracts should be adjusted due to lower-than-expected demand and budgetary pressures. The court's decision, however, upholds the contractual obligations, compelling the nations to take delivery of the vaccines and settle the substantial bill. The order underscores the immense financial liabilities locked into pandemic-era procurement deals.

The ruling places immediate fiscal pressure on Warsaw and Bucharest, potentially forcing difficult budgetary reallocations. It also sets a critical precedent for other EU countries that may have considered challenging their own vaccine purchase commitments. For Pfizer, the verdict is a major victory in enforcing its contracts, but it risks further straining relations with national governments and fueling public debate over the cost and terms of the bloc's centralized pandemic response strategy.